Sign Up Today and Learn More About SamanTree Medical Stock
Invest in or calculate the value of your shares in SamanTree Medical or other pre-IPO companies through EquityZen's platform.
SamanTree Medical Stock
SamanTree Medical is an innovative Swiss company, developing a medical device to acquire tissue images during surgical cancer intervention.
About SamanTree Medical Stock
Founded
2014
Industries
Software, Artificial Intelligence, Data and Analytics
SamanTree Medical Press Mentions
Stay in the know about the latest news on SamanTree Medical
Samantree secures series B extension to take total to $20M
bioworld • Apr 06, 2025
Sample dishes for use in microscopy and methods of their use
patents • Feb 08, 2025
Systems and methods for in-operating-theatre imaging of fresh tissue resected …
patents • Feb 08, 2025
SamanTree Medical legt focus op onderzoek dat 67% minder heroperaties laat zien voor borstsparende chirurgie op de SABCS 2024
businesswire • Dec 12, 2024
SamanTree Medical raises $14 Million in Series B financing round
bioalps • Aug 09, 2024
SamanTree Medical Management
Leadership team at SamanTree Medical
Chair
Chuck Carignan
Board Member
Amine Benmoussa
Join now and verify your accreditation status to gain access to:
- SamanTree Medical Current Valuation
- SamanTree Medical Stock Price
- SamanTree Medical Management
- Available deals in SamanTree Medical and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- SamanTree Medical Cap Table and Funding History by Share Class and Liquidity Preferences
- SamanTree Medical Revenue and Financials
- SamanTree Medical Highlights
- SamanTree Medical Business Model
- SamanTree Medical Risk Factors
- SamanTree Medical Research Report from SACRA Research
Trading SamanTree Medical Stock
How to invest in SamanTree Medical stock?
Accredited investors can buy pre-IPO stock in companies like SamanTree Medical through EquityZen funds. These investments are made available by existing SamanTree Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell SamanTree Medical stock?
Shareholders can sell their SamanTree Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."